• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性 OVA 变应原挑战 TNF p55/p75 受体缺陷型小鼠气道重塑减少。

Chronic OVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling.

机构信息

Department of Medicine, University of California San Diego, San Diego, CA, United States.

出版信息

Int Immunopharmacol. 2011 Aug;11(8):1038-44. doi: 10.1016/j.intimp.2011.02.024. Epub 2011 Mar 5.

DOI:10.1016/j.intimp.2011.02.024
PMID:21382533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3121895/
Abstract

The role of tumor necrosis factor-α (TNF-α) in contributing to allergen induced airway remodeling in asthma is unknown. In this study we have utilized a mouse model of chronic OVA allergen induced airway remodeling to determine whether TNF p55/p75 receptor deficient mice (abbreviated TNF-R KO) had reduced levels of airway remodeling. Chronic OVA challenged WT mice had significantly increased levels of lung eosinophilic inflammation as well as features of airway remodeling including increased peribronchial fibrosis, thickness of the peribronchial smooth muscle layer, mucus expression, and deposition of extracellular matrix proteins. In contrast, TNF-R KO mice had significantly reduced levels of major basic protein positive peribronchial eosinophils and significantly reduced peribronchial fibrosis assessed by quantitating the area of peribronchial trichrome staining and total lung collagen. In addition, TNF-R KO mice had significantly reduced thickness of the peribronchial smooth muscle layer, area of peribronchial α-smooth muscle actin immunostaining, and levels of the extracellular matrix protein fibronectin. There was a non-significant trend for reduced mucus expression in TNF-R KO mice. Levels of peribronchial cells immunostaining positive for TGF-β1 were significantly reduced in TNF-R KO mice suggesting that reduced levels of TGF-β1 expression in TNF-R KO mice may contribute to reduced airway remodeling. Overall, this study suggests an important role for TNF-α in contributing to many features of allergen induced airway remodeling including changes in levels of peribronchial smooth muscle, subepithelial fibrosis, and deposition of extracellular matrix.

摘要

肿瘤坏死因子-α(TNF-α)在哮喘中导致过敏原诱导的气道重塑中的作用尚不清楚。在这项研究中,我们利用慢性 OVA 过敏原诱导的气道重塑小鼠模型来确定 TNF p55/p75 受体缺陷(简称 TNF-R KO)小鼠是否具有较低水平的气道重塑。慢性 OVA 挑战的 WT 小鼠具有显著增加的肺嗜酸性粒细胞炎症以及气道重塑的特征,包括增加的支气管周围纤维化、支气管周围平滑肌层的厚度、粘液表达和细胞外基质蛋白的沉积。相比之下,TNF-R KO 小鼠具有显著减少的主要碱性蛋白阳性支气管周围嗜酸性粒细胞,并且通过定量支气管周围三染色和总肺胶原评估支气管周围纤维化具有显著减少的支气管周围纤维化。此外,TNF-R KO 小鼠具有显著减少的支气管周围平滑肌层的厚度、支气管周围α-平滑肌肌动蛋白免疫染色的面积和细胞外基质蛋白纤连蛋白的水平。TNF-R KO 小鼠的粘液表达减少具有非显著趋势。TNF-R KO 小鼠的支气管周围细胞免疫染色阳性 TGF-β1 的水平显著降低,这表明 TNF-R KO 小鼠中 TGF-β1 表达水平降低可能导致气道重塑减少。总体而言,这项研究表明 TNF-α 在导致过敏原诱导的气道重塑的许多特征中具有重要作用,包括支气管周围平滑肌、上皮下纤维化和细胞外基质沉积水平的变化。

相似文献

1
Chronic OVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling.慢性 OVA 变应原挑战 TNF p55/p75 受体缺陷型小鼠气道重塑减少。
Int Immunopharmacol. 2011 Aug;11(8):1038-44. doi: 10.1016/j.intimp.2011.02.024. Epub 2011 Mar 5.
2
Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13.慢性 OVA 变应原挑战 Siglec-F 缺陷型小鼠有增加的黏液、重塑和上皮 Siglec-F 配体,这些配体受 IL-4 和 IL-13 上调。
Respir Res. 2010 Nov 1;11(1):154. doi: 10.1186/1465-9921-11-154.
3
Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease.肿瘤坏死因子相关凋亡诱导配体调节变应性气道疾病中气道重塑的标志性特征。
Am J Respir Cell Mol Biol. 2014 Jul;51(1):86-93. doi: 10.1165/rcmb.2013-0490OC.
4
Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice.Smad 3基因缺陷小鼠中变应原诱导的气道重塑的抑制作用
J Immunol. 2007 Jun 1;178(11):7310-6. doi: 10.4049/jimmunol.178.11.7310.
5
Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice.变应原激发的基质金属蛋白酶-9缺陷小鼠支气管周围纤维化减轻。
Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L265-71. doi: 10.1152/ajplung.00305.2005.
6
PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling.磷脂酰肌醇-3激酶γ缺陷型小鼠的变应原诱导嗜酸性粒细胞炎症和气道重塑水平降低。
Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L210-9. doi: 10.1152/ajplung.90275.2008. Epub 2008 Nov 21.
7
Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice.皮质类固醇可防止小鼠体内肌成纤维细胞积聚和气道重塑。
Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L162-9. doi: 10.1152/ajplung.00252.2005.
8
Coexposure to environmental tobacco smoke increases levels of allergen-induced airway remodeling in mice.同时暴露于环境烟草烟雾会增加小鼠中过敏原诱导的气道重塑水平。
J Immunol. 2007 Apr 15;178(8):5321-8. doi: 10.4049/jimmunol.178.8.5321.
9
Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen.接触环境烟草烟雾并不能阻止皮质类固醇减轻暴露于过敏原的小鼠的炎症、重塑和气道高反应性。
Am J Physiol Lung Cell Mol Physiol. 2009 Aug;297(2):L380-7. doi: 10.1152/ajplung.90588.2008. Epub 2009 Jun 12.
10
Toll-like receptor-9 agonist inhibits airway inflammation, remodeling and hyperreactivity in mice exposed to chronic environmental tobacco smoke and allergen.Toll 样受体 9 激动剂抑制暴露于慢性环境烟草烟雾和变应原的小鼠气道炎症、重塑和高反应性。
Int Arch Allergy Immunol. 2010;151(4):285-96. doi: 10.1159/000250437. Epub 2009 Oct 22.

引用本文的文献

1
Neutrophils and Asthma.中性粒细胞与哮喘
Diagnostics (Basel). 2022 May 8;12(5):1175. doi: 10.3390/diagnostics12051175.
2
Tumor Necrosis Factor Alpha Inhibits L-Type Ca(2+) Channels in Sensitized Guinea Pig Airway Smooth Muscle through ERK 1/2 Pathway.肿瘤坏死因子α通过ERK 1/2途径抑制致敏豚鼠气道平滑肌中的L型钙通道。
Mediators Inflamm. 2016;2016:5972302. doi: 10.1155/2016/5972302. Epub 2016 Jun 30.
3
TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells.Toll样受体3(TLR3)激活可增加人胎儿气道平滑肌细胞中的趋化因子表达。

本文引用的文献

1
Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner.肿瘤坏死因子通过依赖 PI3Kγ的超氧化物产生,以不同的方式诱导心肌细胞和成纤维细胞中的基质金属蛋白酶。
Am J Physiol Cell Physiol. 2010 Mar;298(3):C679-92. doi: 10.1152/ajpcell.00351.2009. Epub 2009 Dec 9.
2
Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.肿瘤坏死因子-α通过促进透明质酸-CD44-肌动蛋白结合促进转化生长因子-β依赖性上皮间质转化。
J Biol Chem. 2010 Feb 5;285(6):4060-4073. doi: 10.1074/jbc.M109.056523. Epub 2009 Dec 4.
3
Am J Physiol Lung Cell Mol Physiol. 2016 Jan 15;310(2):L202-11. doi: 10.1152/ajplung.00151.2015. Epub 2015 Nov 20.
4
Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation.在嗜中性粒细胞性气道炎症小鼠模型中,中和肿瘤坏死因子α可恢复糖皮质激素敏感性。
Mucosal Immunol. 2015 Nov;8(6):1212-25. doi: 10.1038/mi.2015.12. Epub 2015 Mar 11.
5
HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts.在慢性哮喘小鼠模型中,高迁移率族蛋白B1(HMGB1)通过调节气道炎症和激活肺成纤维细胞,促进变应原诱导的气道重塑。
Cell Mol Immunol. 2015 Jul;12(4):409-23. doi: 10.1038/cmi.2014.60. Epub 2014 Aug 25.
6
Systems biology approaches to understanding Epithelial Mesenchymal Transition (EMT) in mucosal remodeling and signaling in asthma.系统生物学方法研究黏膜重塑和哮喘信号中的上皮间质转化(EMT)。
World Allergy Organ J. 2014 Jun 2;7(1):13. doi: 10.1186/1939-4551-7-13. eCollection 2014.
7
Endothelial and leukocyte heparan sulfates regulate the development of allergen-induced airway remodeling in a mouse model.内皮细胞和白细胞硫酸乙酰肝素在小鼠模型中调节变应原诱导的气道重塑的发展。
Glycobiology. 2014 Aug;24(8):715-27. doi: 10.1093/glycob/cwu035. Epub 2014 May 2.
8
Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells.人骨髓间充质干细胞抑制支气管上皮细胞牵张诱导的炎症 microRNA-155 和细胞因子。
PLoS One. 2013 Aug 13;8(8):e71342. doi: 10.1371/journal.pone.0071342. eCollection 2013.
9
Role of TNFR1 in the innate airway hyperresponsiveness of obese mice.肥胖小鼠固有气道高反应性中 TNFR1 的作用。
J Appl Physiol (1985). 2012 Nov;113(9):1476-85. doi: 10.1152/japplphysiol.00588.2012. Epub 2012 Sep 13.
10
The airway epithelium in asthma.哮喘中的气道上皮。
Nat Med. 2012 May 4;18(5):684-92. doi: 10.1038/nm.2737.
TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water.
TNF-α 抑制剂在哮喘和 COPD 中的应用:我们不能因噎废食。
Pulm Pharmacol Ther. 2010 Apr;23(2):121-8. doi: 10.1016/j.pupt.2009.10.007. Epub 2009 Oct 22.
4
Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling.抗唾液酸结合免疫球蛋白样凝集素-F抗体可减轻变应原诱导的嗜酸性粒细胞炎症和气道重塑。
J Immunol. 2009 Oct 15;183(8):5333-41. doi: 10.4049/jimmunol.0801421. Epub 2009 Sep 25.
5
TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice.TNF-α 驱动小鼠持续性气道炎症中血管和淋巴管的重塑。
J Clin Invest. 2009 Oct;119(10):2954-64. doi: 10.1172/JCI37626. Epub 2009 Sep 14.
6
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.一项关于肿瘤坏死因子-α阻断剂治疗重度持续性哮喘的随机、双盲、安慰剂对照研究。
Am J Respir Crit Care Med. 2009 Apr 1;179(7):549-58. doi: 10.1164/rccm.200809-1512OC. Epub 2009 Jan 8.
7
Severe exacerbations and decline in lung function in asthma.哮喘的严重急性加重和肺功能下降
Am J Respir Crit Care Med. 2009 Jan 1;179(1):19-24. doi: 10.1164/rccm.200807-1126OC. Epub 2008 Oct 31.
8
The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.可溶性肿瘤坏死因子α受体融合蛋白(依那西普)在皮质类固醇难治性哮喘中的作用:一项双盲、随机、安慰剂对照试验。
Thorax. 2008 Jul;63(7):584-91. doi: 10.1136/thx.2007.086314. Epub 2008 Feb 1.
9
Mast cell-derived tumour necrosis factor is essential for allergic airway disease.肥大细胞衍生的肿瘤坏死因子对过敏性气道疾病至关重要。
Eur Respir J. 2008 Apr;31(4):773-82. doi: 10.1183/09031936.00058907. Epub 2007 Dec 19.
10
Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice.Smad 3基因缺陷小鼠中变应原诱导的气道重塑的抑制作用
J Immunol. 2007 Jun 1;178(11):7310-6. doi: 10.4049/jimmunol.178.11.7310.